Published in Appl Environ Microbiol on November 03, 2006
Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol (2010) 2.31
Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol (2008) 2.18
Bacteriophage endolysins as novel antimicrobials. Future Microbiol (2012) 1.68
Transducing particles of Staphylococcus aureus pathogenicity island SaPI1 are comprised of helper phage-encoded proteins. J Bacteriol (2007) 1.53
Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J Bacteriol (2008) 1.28
Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol (2008) 1.26
Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc Natl Acad Sci U S A (2011) 1.22
Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs (2011) 1.13
The lactococcal phages Tuc2009 and TP901-1 incorporate two alternate forms of their tail fiber into their virions for infection specialization. J Biol Chem (2013) 1.11
X-ray crystal structure of the streptococcal specific phage lysin PlyC. Proc Natl Acad Sci U S A (2012) 1.11
LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol (2010) 1.07
Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J Bacteriol (2011) 1.05
Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol (2011) 1.01
Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci (2012) 1.00
Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme. FEMS Microbiol Lett (2013) 0.98
In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases. Antimicrob Agents Chemother (2011) 0.96
Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus. Appl Microbiol Biotechnol (2012) 0.96
In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. Antimicrob Agents Chemother (2011) 0.96
Engineered bacteriophage lysins as novel anti-infectives. Front Microbiol (2014) 0.95
The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice. Bioeng Bugs (2011) 0.94
Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci. Curr Microbiol (2009) 0.93
Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage (2015) 0.92
Purification and activity testing of the full-length YycFGHI proteins of Staphylococcus aureus. PLoS One (2012) 0.92
Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl Environ Microbiol (2012) 0.92
LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci. Curr Microbiol (2011) 0.91
Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS One (2014) 0.90
Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. Appl Environ Microbiol (2011) 0.89
Insights into Bacteriophage Application in Controlling Vibrio Species. Front Microbiol (2016) 0.86
Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms. Int J Microbiol (2013) 0.86
Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses (2014) 0.85
Genomic sequence and characterization of the virulent bacteriophage phiCTP1 from Clostridium tyrobutyricum and heterologous expression of its endolysin. Appl Environ Microbiol (2010) 0.85
Structural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysin. PLoS Pathog (2014) 0.84
Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'. J Biotechnol (2012) 0.84
Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J Antimicrob Chemother (2015) 0.82
Staphylococcal phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site. Appl Microbiol Biotechnol (2012) 0.82
In silico modeling of the staphylococcal bacteriophage-derived peptidase CHAP(K). Bacteriophage (2011) 0.81
Staphylococcus aureus and Chronic Airway Disease. World Allergy Organ J (2010) 0.81
Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease. Mol Microbiol (2016) 0.81
Lytic activity of LysH5 endolysin secreted by Lactococcus lactis using the secretion signal sequence of bacteriocin Lcn972. Appl Environ Microbiol (2012) 0.80
Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus. Sci Rep (2016) 0.80
Biofilm-degrading enzymes from Lysobacter gummosus. Virulence (2014) 0.80
Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides. Appl Environ Microbiol (2015) 0.79
Vibriophages Differentially Influence Biofilm Formation by Vibrio anguillarum Strains. Appl Environ Microbiol (2015) 0.79
Lytic activity of the staphylolytic Twort phage endolysin CHAP domain is enhanced by the SH3b cell wall binding domain. FEMS Microbiol Lett (2014) 0.79
Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry. Front Microbiol (2016) 0.78
Bacteriophage PBC1 and its endolysin as an antimicrobial agent against Bacillus cereus. Appl Environ Microbiol (2015) 0.78
Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium. Poult Sci (2013) 0.78
Expression and lytic efficacy assessment of the Staphylococcus aureus phage SA4 lysin gene. J Vet Sci (2013) 0.77
Properties and mutation studies of a bacteriophage-derived chimeric recombinant staphylolytic protein P128: Comparison to recombinant lysostaphin. Bacteriophage (2013) 0.77
A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa. Front Microbiol (2017) 0.76
Expression of Recombinant pET22b-LysK-Cysteine/Histidine-Dependent Amidohydrolase/Peptidase Bacteriophage Therapeutic Protein in Escherichia coli BL21 (DE3). Osong Public Health Res Perspect (2015) 0.76
Downregulation of Autolysin-Encoding Genes by Phage-Derived Lytic Proteins Inhibits Biofilm Formation in Staphylococcus aureus. Antimicrob Agents Chemother (2017) 0.75
A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus. Front Cell Infect Microbiol (2017) 0.75
Bacteriophage Lysin CF-301: a Potent Anti-Staphylococcal Biofilm Agent. Antimicrob Agents Chemother (2017) 0.75
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol (1986) 55.34
Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58
Bacterial biofilms in nature and disease. Annu Rev Microbiol (1987) 16.14
Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol (2001) 11.67
Staphylococcus and biofilms. Mol Microbiol (2002) 6.39
Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47
Global gene expression in Staphylococcus aureus biofilms. J Bacteriol (2004) 4.46
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun (1996) 3.95
Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol (2002) 3.57
Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61
Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325. Gene (2002) 2.30
The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci (2003) 2.29
Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis (2001) 2.10
Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem (1999) 2.05
Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother (2005) 1.91
Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J (1996) 1.82
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82
Influence of agr on fibrinogen binding in Staphylococcus aureus Newman. Infect Immun (1996) 1.81
Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem (2005) 1.79
Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol (2006) 1.72
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother (2003) 1.69
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol (2005) 1.63
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2001) 1.48
Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J Biol Chem (2005) 1.48
Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics (2002) 1.44
Growth-rate-independent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis; evidence for cell-cycle dependency. J Antimicrob Chemother (1992) 1.35
Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology (2003) 1.34
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother (2005) 1.33
The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiol Lett (1998) 1.33
Role of fibronectin in staphylococcal adhesion to metallic surfaces used as models of orthopaedic devices. J Orthop Res (1994) 0.99
Reduced adherence and host cell invasion by methicillin-resistant Staphylococcus aureus expressing the surface protein Pls. J Infect Dis (2004) 0.99
Modification of autolysis by synthetic peptides derived from the presumptive binding domain of Staphylococcus aureus autolysin. Microbiol Immunol (2000) 0.82
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob Agents Chemother (2003) 1.67
Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. Int J Med Microbiol (2007) 1.57
Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol (2003) 1.48
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother (2004) 1.35
Analysis of the matrix-assisted laser desorption ionization-time of flight mass spectrum of Staphylococcus aureus identifies mutations that allow differentiation of the main clonal lineages. J Clin Microbiol (2013) 1.34
Dissecting structural and functional diversity of the lantibiotic mersacidin. Chem Biol (2009) 1.25
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J Biol Chem (2003) 1.25
An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2002) 1.24
Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin. Appl Environ Microbiol (2003) 1.20
Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One (2009) 1.14
Role of the single regulator MrsR1 and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. Appl Environ Microbiol (2002) 1.07
Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int J Med Microbiol (2008) 1.05
Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides. Int J Med Microbiol (2009) 1.05
Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. Int J Med Microbiol (2010) 1.00
Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus. BMC Genomics (2007) 0.97
The lantibiotic mersacidin is an autoinducing peptide. Appl Environ Microbiol (2006) 0.97
Detection of astrovirus in premature infants with necrotizing enterocolitis. Pediatr Infect Dis J (2008) 0.95
The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol (2002) 0.93
Purification and activity testing of the full-length YycFGHI proteins of Staphylococcus aureus. PLoS One (2012) 0.92
The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol (2008) 0.92
Marine myxobacteria as a source of antibiotics--comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina. Mar Drugs (2010) 0.87
Antibiotic-induced autoactivation of IS256 in Staphylococcus aureus. Antimicrob Agents Chemother (2013) 0.87
Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42. PLoS One (2011) 0.86
Revisiting the genomes of the Staphylococcus aureus strains NCTC 8325 and RN4220. Int J Med Microbiol (2012) 0.86
Salimabromide: unexpected chemistry from the obligate marine myxobacterium Enhygromxya salina. Chemistry (2013) 0.84
Understanding the physiology and adaptation of staphylococci: a post-genomic approach. Int J Med Microbiol (2007) 0.84
Salimyxins and enhygrolides: antibiotic, sponge-related metabolites from the obligate marine myxobacterium Enhygromyxa salina. Chembiochem (2013) 0.82
Diversification of clonal complex 5 methicillin-resistant Staphylococcus aureus strains (Rhine-Hesse clone) within Germany. J Clin Microbiol (2012) 0.80
Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility. BMC Microbiol (2013) 0.80
Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics. J Bacteriol (2012) 0.79
Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar strains in isolates from children and their parents. J Clin Microbiol (2007) 0.78